🎉 M&A multiples are live!
Check it out!

Sepax Technologies Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sepax Technologies and similar public comparables like Proteomics International, Biohit, and AnteoTech.

Sepax Technologies Overview

About Sepax Technologies

Suzhou Sepax Technologies Co Ltd is engaged in the Research, development and produce liquid chromatography materials for drug analysis, detection, separation and purification.


Founded

2009

HQ

China
Employees

n/a

Financials

LTM Revenue $45.4M

LTM EBITDA n/a

EV

$964M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Sepax Technologies Financials

Sepax Technologies has a last 12-month revenue of $45.4M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Sepax Technologies achieved revenue of $33.8M and an EBITDA of $11.3M.

Sepax Technologies expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Sepax Technologies valuation multiples based on analyst estimates

Sepax Technologies P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $29.3M $33.8M XXX XXX XXX
Gross Profit $15.2M $22.4M XXX XXX XXX
Gross Margin 52% 66% XXX XXX XXX
EBITDA $9.6M $11.3M XXX XXX XXX
EBITDA Margin 33% 33% XXX XXX XXX
Net Profit $2.9M $6.5M XXX XXX XXX
Net Margin 10% 19% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Sepax Technologies Stock Performance

As of April 15, 2025, Sepax Technologies's stock price is CNY 17 (or $2).

Sepax Technologies has current market cap of CNY 7.1B (or $980M), and EV of CNY 7.0B (or $964M).

See Sepax Technologies trading valuation data

Sepax Technologies Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$964M $980M XXX XXX XXX XXX $0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Sepax Technologies Valuation Multiples

As of April 15, 2025, Sepax Technologies has market cap of $980M and EV of $964M.

Sepax Technologies's trades at 21.2x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Sepax Technologies's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Sepax Technologies and 10K+ public comps

Sepax Technologies Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $964M XXX XXX XXX
EV/Revenue 28.5x XXX XXX XXX
EV/EBITDA 85.5x XXX XXX XXX
P/E 135.5x XXX XXX XXX
P/E/Growth 2.6x XXX XXX XXX
EV/FCF 288.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Sepax Technologies Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Sepax Technologies Valuation Multiples

Sepax Technologies's NTM/LTM revenue growth is 22%

Sepax Technologies's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Sepax Technologies's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Sepax Technologies's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Sepax Technologies and other 10K+ public comps

Sepax Technologies Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 15% XXX XXX XXX XXX
EBITDA Margin 33% XXX XXX XXX XXX
EBITDA Growth 17% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 55% XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue 3% XXX XXX XXX XXX
G&A Expenses to Revenue 6% XXX XXX XXX XXX
R&D Expenses to Revenue 18% XXX XXX XXX XXX
Opex to Revenue 49% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Sepax Technologies Public Comps

See public comps and valuation multiples for Pharma Diagnostics & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Zomedica XXX XXX XXX XXX XXX XXX
AnteoTech XXX XXX XXX XXX XXX XXX
Proteomics International XXX XXX XXX XXX XXX XXX
Biohit XXX XXX XXX XXX XXX XXX
Genomictree XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Sepax Technologies M&A and Investment Activity

Sepax Technologies acquired  XXX companies to date.

Last acquisition by Sepax Technologies was  XXXXXXXX, XXXXX XXXXX XXXXXX . Sepax Technologies acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Sepax Technologies

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Sepax Technologies

When was Sepax Technologies founded? Sepax Technologies was founded in 2009.
Where is Sepax Technologies headquartered? Sepax Technologies is headquartered in China.
Is Sepax Technologies publicy listed? Yes, Sepax Technologies is a public company listed on SHG.
What is the stock symbol of Sepax Technologies? Sepax Technologies trades under 688758 ticker.
When did Sepax Technologies go public? Sepax Technologies went public in 2025.
Who are competitors of Sepax Technologies? Similar companies to Sepax Technologies include e.g. Zomedica, AnteoTech, Proteomics International, Biohit.
What is the current market cap of Sepax Technologies? Sepax Technologies's current market cap is $980M
What is the current revenue of Sepax Technologies? Sepax Technologies's last 12-month revenue is $45.4M.
What is the current EV/Revenue multiple of Sepax Technologies? Current revenue multiple of Sepax Technologies is 21.2x.
What is the current revenue growth of Sepax Technologies? Sepax Technologies revenue growth between 2023 and 2024 was 15%.
Is Sepax Technologies profitable? Yes, Sepax Technologies is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.